Connect BiopharmaL logo

Connect BiopharmaL Share Price Today

(NASDAQ: CNTB)

Connect BiopharmaL share price is $1.05 & ₹91.95 as on 7 Feb 2025, 2.30 'hrs' IST

$1.05

Market is closed - opens 8 PM, 07 Feb 2025

View live Connect BiopharmaL share price in Dollar and Rupees. Guide to invest in Connect BiopharmaL stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Connect BiopharmaL, along with analyst recommendations, forecasts, and comprehensive financials.

Connect BiopharmaL share price movements

  • Today's Low: $0.98
    Today's High: $1.07

    Day's Volatility :8.4%

  • 52 Weeks Low: $0.91
    52 Weeks High: $2.66

    52 Weeks Volatility :65.75%

Connect BiopharmaL (CNTB) Returns

PeriodConnect Biopharma Holdings LSector (Health Care)Index (Russel 2000)
3 Months
-6.25%
-1.3%
0.0%
6 Months
-1.88%
0.8%
0.0%
1 Year
-5.41%
1.9%
0.0%
3 Years
-77.52%
11.4%
-12.1%

Connect BiopharmaL (CNTB) Key Statistics

in dollars & INR

Previous Close
$1.05
Open
$1.07
Today's High
$1.07
Today's Low
$0.9801
Market Capitalization
$58.0M
Today's Volume
$23.4K
52 Week High
$2.66
52 Week Low
$0.911
Revenue TTM
$24.1M
EBITDA
$-25.0M
Earnings Per Share (EPS)
$-0.39
Profit Margin
-88.66%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-17.92%

How to invest in Connect BiopharmaL Stock (CNTB) from India?

It is very easy for Indian residents to invest directly in Connect BiopharmaL from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Connect BiopharmaL stock in both Indian Rupees (INR) and US Dollars (USD). Search for Connect BiopharmaL or CNTB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Connect BiopharmaL or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Connect BiopharmaL shares which would translate to 0.834 fractional shares of Connect BiopharmaL as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Connect BiopharmaL, in just a few clicks!

Returns in Connect BiopharmaL (CNTB) for Indian investors in Rupees

The Connect BiopharmaL stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Connect BiopharmaL investment value today

Current value as on today

₹1,00,179

Returns

₹179

(+0.18%)

Returns from Connect BiopharmaL Stock

₹5,405 (-5.41%)

Dollar Returns

₹5,585 (+5.58%)

Indian investors sentiment towards Connect BiopharmaL (CNTB)

36%

Period: Jan 7, 2025 to Feb 6, 2025. Change in 30 Days versus previous period

Search interest for Connect BiopharmaL Stock from India on INDmoney has increased by 36% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Connect BiopharmaL

  • BML Capital Management LLC

    3.79%

  • UBS O'Connor LLC

    0.92%

  • Renaissance Technologies Corp

    0.32%

  • RSM US WEALTH MANAGEMENT LLC

    0.29%

  • Callan Capital, LLC

    0.08%

  • Royal Bank of Canada

    0.06%

Analyst Recommendation on Connect BiopharmaL

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Connect BiopharmaL(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Connect BiopharmaL Stock (CNTB)

What analysts predicted

Upside of 566.67%

Target:

$7.00

Current:

$1.05

Insights on Connect BiopharmaL Stock (Ticker Symbol: CNTB)

  • Price Movement

    In the last 7 days, CNTB stock has moved up by 8.0%
  • CNTB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 65.0% return, outperforming this stock by 74.5%
  • CNTB vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 87.2% return, outperforming this stock by 166.0%
  • Price to Sales

    ForCNTB every $1 of sales, investors are willing to pay $2.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.8 for every $1 of sales.

Connect BiopharmaL Technicals Summary

Sell

Neutral

Buy

Connect BiopharmaL is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Connect BiopharmaL (CNTB) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Connect Biopharma Holdings L logo
-5.83%
-1.88%
-5.41%
-77.52%
-94.91%
Biontech Se logo
-1.81%
48.44%
27.46%
-24.85%
273.41%
Regeneron Pharmaceuticals, Inc. logo
-1.57%
-36.17%
-23.71%
16.85%
86.96%
Vertex Pharmaceuticals Incorporated logo
16.76%
2.71%
13.73%
99.7%
96.59%
Alnylam Pharmaceuticals, Inc. logo
15.67%
3.24%
64.16%
88.47%
111.6%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Connect Biopharma Holdings L logo
NA
NA
NA
-0.21
-0.18
-0.12
NA
2.0
Biontech Se logo
160.8
NA
0.04
-3.29
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
18.69
18.69
1.15
43.75
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.28
0.48
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Connect Biopharma Holdings L logo
Buy
$58.0M
-94.91%
NA
-88.66%
Biontech Se logo
Buy
$29.3B
273.41%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$78.4B
86.96%
18.69
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$125.8B
96.59%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.6B
111.6%
NA
-15.86%

About Connect BiopharmaL

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma, currently under Phase 3 studies; and icanbelimod (formerly CBP-307), an oral small molecule Sphingosine 1-Phosphate Receptor 1 modulator, currently under Phase 2 clinical for the treatment of ulcerative colitis and Crohn's disease. The company was founded in 2012 and is based in San Diego, California.
Organization
Connect BiopharmaL
Employees
81
CEO
Dr. Barry D. Quart Pharm.D.
Industry
Healthcare

Management People of Connect BiopharmaL

NameTitle
Dr. Barry D. Quart Pharm.D.
CEO & Director
Mr. David L. Szekeres J.D.
President
Ms. Lisa Peraza CPA
Vice President of Finance
Mr. Jeff Cohn J.D.
General Counsel & Corporate Secretary
Dr. Lei Sun Ph.D.
VP of Biologics & Head of CMC
Dr. Raul Collazo Ph.D.
VP & Global Head of Medical Affairs
Dr. Srikanth Pendyala M.D.
Senior Vice President of Clinical Development(Consultant)
Ms. Kimberly J. Manhard
Chief Development Officer

Important FAQs about investing in CNTB Stock from India :

What is Connect BiopharmaL share price today?

Connect BiopharmaL share price today stands at $1.05, Open: $1.07 ; Previous Close: $1.05 ; High: $1.07 ; Low: $0.98 ; 52 Week High: $2.66 ; 52 Week Low: $0.91.

The stock opens at $1.07, after a previous close of $1.05. The stock reached a daily high of $1.07 and a low of $0.98, with a 52-week high of $2.66 and a 52-week low of $0.91.

Can Indians buy Connect BiopharmaL shares?

Yes, Indians can invest in the Connect BiopharmaL (CNTB) from India.

With INDmoney, you can buy Connect BiopharmaL at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Connect BiopharmaL at zero transaction cost.

How can I buy Connect BiopharmaL shares from India?

It is very easy to buy Connect BiopharmaL from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Connect BiopharmaL (CNTB) be purchased?

Yes, you can buy fractional shares of Connect BiopharmaL with INDmoney app.

What are the documents required to start investing in Connect BiopharmaL stocks?

To start investing in Connect BiopharmaL, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Connect BiopharmaL Stock (CNTB)?

Today’s highest price of Connect BiopharmaL (CNTB) is $1.07.

Today’s lowest price of Connect BiopharmaL (CNTB) is $0.98.

What is today's market capitalisation of Connect BiopharmaL?

Today's market capitalisation of Connect BiopharmaL CNTB is 58.0M

What is the 52 Week High and Low Range of Connect BiopharmaL Stock (CNTB)?

  • 52 Week High

    $2.66

  • 52 Week Low

    $0.91

What are the historical returns of Connect BiopharmaL (CNTB)?

  • 1 Month Returns

    -5.83%

  • 3 Months Returns

    -1.88%

  • 1 Year Returns

    -5.41%

  • 5 Years Returns

    -94.91%

Who is the Chief Executive Officer (CEO) of Connect BiopharmaL ?

Dr. Barry D. Quart Pharm.D. is the current Chief Executive Officer (CEO) of Connect BiopharmaL.

Discover More